Aktie A2JGJZ COGNETIVITY NEUROSCIENCES LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Cognetivity Neurosciences Ltd.

Aktien

A2JGJZ

CA19243C1005

CGN

Verzögert Canadian Securities Exchange
Andere Börsenplätze
 16:21:15 01.05.2024 		% 5 Tage % 1. Jan.
0,015 CAD -25,00 % Intraday Chart für Cognetivity Neurosciences Ltd. -25,00 % 0,00 %
2023 Cognetivity Neurosciences Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Oktober 2023 CI
2023 Cognetivity Neurosciences Ltd. und Uc Health arbeiten zusammen, um die Früherkennung von kognitiven Beeinträchtigungen in den USA zu verbessern CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023
CognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service
Cognetivity Neurosciences Ltd. announced that it has received CAD 0.01 million in funding
Cognetivity Neurosciences Ltd. and Uc Health Partner to Improve Early Detection of Cognitive Impairment in Usa
Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA
Cognetivity Neurosciences Ltd. Announces Collaboration with the Mediclinic Group
Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023
Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology
Cognetivity Neurosciences Ltd. announced that it expects to receive CAD 0.01 million in funding
Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award
Cognetivity Neurosciences Ltd. Announces Eisai's Leqembi Approval for the Treatment of Alzheimer's Disease
Cognetivity Neurosciences Ltd. Reports Earnings Results for the First Quarter Ended April 30, 2023
Clairvo Technologies, Inc. Announces Strategic Partnership with Cognetivity Neurosciences, Inc
Cognetivity Neurosciences Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023
Cognetivity Neurosciences Ltd. Auditor Raises 'Going Concern' Doubt
Cognetivity Neurosciences Ltd. Announces Collaboration with the Alzheimer's Society to Further Expand Its AI Algorithms
Cognetivity Neurosciences Ltd. Announces Agreement with Mitsui Sumitomo Aioi Life Insurance of Japan to Provide CognICA Technology to Customers
Cognetivity Neurosciences : Announces Agreement With Japanese Life Insurance Company
Cognetivity Neurosciences Ltd. Appoints Karimah Es Sabar to Its Board Director
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JGJZ Aktie
  4. Nachrichten Cognetivity Neurosciences Ltd.
  5. Andere Sprachen